Davidson Capital Management Inc. Sells 652 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Davidson Capital Management Inc. lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 10.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,587 shares of the healthcare conglomerate’s stock after selling 652 shares during the period. UnitedHealth Group comprises about 0.9% of Davidson Capital Management Inc.’s portfolio, making the stock its 25th largest holding. Davidson Capital Management Inc.’s holdings in UnitedHealth Group were worth $3,267,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. Tealwood Asset Management Inc. acquired a new position in UnitedHealth Group during the third quarter worth $2,905,000. Asset Planning Services Inc. LA ADV grew its position in shares of UnitedHealth Group by 1.2% in the 3rd quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock valued at $7,288,000 after acquiring an additional 150 shares during the period. Vantage Investment Partners LLC raised its holdings in shares of UnitedHealth Group by 42.2% in the 1st quarter. Vantage Investment Partners LLC now owns 152,107 shares of the healthcare conglomerate’s stock valued at $75,247,000 after purchasing an additional 45,173 shares during the period. Sequoia Financial Advisors LLC grew its holdings in UnitedHealth Group by 13.7% during the third quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock worth $14,603,000 after purchasing an additional 3,006 shares during the period. Finally, Maryland State Retirement & Pension System raised its stake in UnitedHealth Group by 0.6% in the first quarter. Maryland State Retirement & Pension System now owns 72,689 shares of the healthcare conglomerate’s stock valued at $35,126,000 after buying an additional 469 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Down 0.6 %

Shares of UNH opened at $562.13 on Wednesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $608.63. The firm has a market cap of $519.08 billion, a price-to-earnings ratio of 36.62, a PEG ratio of 1.66 and a beta of 0.58. The business’s fifty day moving average is $582.88 and its 200-day moving average is $540.32.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.56 earnings per share. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.49%. UnitedHealth Group’s payout ratio is presently 54.72%.

Analyst Ratings Changes

A number of research firms recently weighed in on UNH. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and increased their price target for the company from $481.00 to $647.00 in a research note on Wednesday, July 17th. Wells Fargo & Company raised their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. KeyCorp started coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective for the company. TD Cowen increased their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Finally, Morgan Stanley decreased their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.